Who Buys Ghrita from India — 96 Importers Behind a $458.1K Market

The importers of Ghrita from India can be categorized into several segments:

1. Distributors: Entities that purchase Ghrita in bulk to supply to various retailers or healthcare providers. For instance, SWASTHYAM AYURVEDA HANDEL in Germany, accounting for $0.33 million in imports, likely operates as a distributor, given the substantial volume imported.

2. Hospital Groups: Healthcare institutions procuring Ghrita for therapeutic use within their facilities. An example is KEM EVANG, KLINIKEN ESSEN-MITTE-GG in Germany, importing $0.02 million worth of Ghrita, suggesting usage within their clinical settings.

3. Retail Chains: Businesses that import Ghrita to sell directly to consumers through their retail outlets. While specific retail chains are not explicitly listed among the top buyers, entities like SUCCESS ADVANCE TRADING in Malaysia, with imports totaling $0.01 million, may function in this capacity.

4. Government Procurement: Government bodies or agencies acquiring Ghrita for public health initiatives. The OFFICER IN CHARGE, CENTRAL SUPPLIES in Mauritius, importing $0.01 million worth of Ghrita, exemplifies this segment, likely for distribution within public healthcare programs.

5. Re-exporters: Companies that import Ghrita with the intention of exporting it to other markets. Entities such as SABHA GENERAL TRADING CO LLC and AL NASAMAT GENERAL TRADING CO. in the United Arab Emirates, each importing smaller quantities, may be involved in re-export activities, leveraging the UAE's strategic position as a trade hub.

6. Contract Manufacturers: Firms that import Ghrita as a raw material for the production of other products. While not explicitly identified among the top buyers, such entities could exist within the broader buyer landscape.

Typical buying behaviors vary across these segments. Distributors and retail chains often place larger, regular orders to maintain consistent supply chains. Hospital groups and government procurement agencies may order based on specific healthcare needs or program requirements, leading to variable order patterns. Re-exporters might place orders aligned with demand fluctuations in their target export markets.

For the top five importing countries, the import regulations for Ghrita (HS Code: 30049011) are as follows:

The demand for Ghrita in importing countries is influenced by several factors:

1. Disease Prevalence: Ghrita, often used in Ayurvedic medicine, is sought after for its therapeutic properties in managing chronic conditions such as arthritis, digestive disorders, and certain skin ailments. The prevalence of these conditions in countries like Germany and the United States contributes to sustained demand.

2. Government Healthcare Programs: Countries with established traditional medicine practices, such as Malaysia and Mauritius, incorporate products like Ghrita into their public health initiatives, promoting its use through government-sponsored programs.

3. Universal Health Coverage Expansion: Nations expanding their healthcare coverage, including the UAE, are integrating alternative medicines into their healthcare systems, thereby increasing the accessibility and demand for products like Ghrita.

4. WHO Essential Medicines List Procurement: While Ghrita is not listed on the WHO Essential Medicines List, the growing global interest in traditional and complementary medicines has led to increased procurement by health organizations aiming to diversify treatment options.

5. Tender-Based Purchasing: Government and large healthcare institutions often procure medicinal products through tender systems. The inclusion of Ghrita in such tenders, especially in countries with a high prevalence of chronic diseases, presents significant market opportunities.

With 96 buyers across 24 countries, the market for Ghrita demonstrates a broad and diverse demand base. The high repeat buyer rate of 77.1% indicates strong customer satisfaction and sustained demand, suggesting a stable and growing market for Ghrita in the international pharmaceutical landscape.

The importers of Ghrita from India can be categorized into several segments:

1. Distributors: Entities that purchase Ghrita in bulk to supply to various retailers or healthcare providers. For instance, SWASTHYAM AYURVEDA HANDEL in Germany, accounting for $0.33 million in imports, likely operates as a distributor, given the substantial volume imported.

2. Hospital Groups: Healthcare institutions procuring Ghrita for therapeutic use within their facilities. An example is KEM EVANG, KLINIKEN ESSEN-MITTE-GG in Germany, importing $0.02 million worth of Ghrita, suggesting usage within their clinical settings.

3. Retail Chains: Businesses that import Ghrita to sell directly to consumers through their retail outlets. While specific retail chains are not explicitly listed among the top buyers, entities like SUCCESS ADVANCE TRADING in Malaysia, with imports totaling $0.01 million, may function in this capacity.

4. Government Procurement: Government bodies or agencies acquiring Ghrita for public health initiatives. The OFFICER IN CHARGE, CENTRAL SUPPLIES in Mauritius, importing $0.01 million worth of Ghrita, exemplifies this segment, likely for distribution within public healthcare programs.

5. Re-exporters: Companies that import Ghrita with the intention of exporting it to other markets. Entities such as SABHA GENERAL TRADING CO LLC and AL NASAMAT GENERAL TRADING CO. in the United Arab Emirates, each importing smaller quantities, may be involved in re-export activities, leveraging the UAE's strategic position as a trade hub.

6. Contract Manufacturers: Firms that import Ghrita as a raw material for the production of other products. While not explicitly identified among the top buyers, such entities could exist within the broader buyer landscape.

Typical buying behaviors vary across these segments. Distributors and retail chains often place larger, regular orders to maintain consistent supply chains. Hospital groups and government procurement agencies may order based on specific healthcare needs or program requirements, leading to variable order patterns. Re-exporters might place orders aligned with demand fluctuations in their target export markets.

For the top five importing countries, the import regulations for Ghrita (HS Code: 30049011) are as follows:

The demand for Ghrita in importing countries is influenced by several factors:

1. Disease Prevalence: Ghrita, often used in Ayurvedic medicine, is sought after for its therapeutic properties in managing chronic conditions such as arthritis, digestive disorders, and certain skin ailments. The prevalence of these conditions in countries like Germany and the United States contributes to sustained demand.

2. Government Healthcare Programs: Countries with established traditional medicine practices, such as Malaysia and Mauritius, incorporate products like Ghrita into their public health initiatives, promoting its use through government-sponsored programs.

3. Universal Health Coverage Expansion: Nations expanding their healthcare coverage, including the UAE, are integrating alternative medicines into their healthcare systems, thereby increasing the accessibility and demand for products like Ghrita.

4. WHO Essential Medicines List Procurement: While Ghrita is not listed on the WHO Essential Medicines List, the growing global interest in traditional and complementary medicines has led to increased procurement by health organizations aiming to diversify treatment options.

5. Tender-Based Purchasing: Government and large healthcare institutions often procure medicinal products through tender systems. The inclusion of Ghrita in such tenders, especially in countries with a high prevalence of chronic diseases, presents significant market opportunities.

With 96 buyers across 24 countries, the market for Ghrita demonstrates a broad and diverse demand base. The high repeat buyer rate of 77.1% indicates strong customer satisfaction and sustained demand, suggesting a stable and growing market for Ghrita in the international pharmaceutical landscape.